Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX ... it is trading below the mean price target of $178.25. On the date of publication, Sohini Mondal did not have ...

StockNews.com lowered shares of Quest Diagnostics from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Robert W. Baird set a $189.00 price target on Quest ...

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

Donnelly downgraded Quest Diagnostics (NYSE:DGX) to Neutral from Buy but maintained his price target at $185 per share. “Our positive thesis has largely played out with the core diagnostics ...

Grail shares are trading higher Wednesday after the company announced a new collaboration with Quest Diagnostics aimed at improving provider access to its Galleri multi-cancer early detection test.

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS ...